J P Maffrand

The Antiaggregating Activity of Clopidogrel Is due to a Metabolic Activation by the Hepatic Cytochrome P450-1A

J. Herbert, J. Maffrand, P. Savi, 1994, Thrombosis and Haemostasis.

Characterization of specific binding sites for [3H]-staurosporine on various protein kinases.

J. Herbert, J. Maffrand, J P Maffrand, 1990, Biochemical and biophysical research communications.

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.

J. Simiand, P. Soubrié, R. Boigegrain, 1999, The Journal of pharmacology and experimental therapeutics.

Chelerythrine is a potent and specific inhibitor of protein kinase C.

J. Herbert, J. Augereau, J. Gleye, 1990, Biochemical and biophysical research communications.

Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits.

J. Herbert, J. Maffrand, J P Maffrand, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.